Literature DB >> 4408304

Marathon running after myocardial infarction.

T Kavanagh, R H Shephard, V Pandit.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4408304

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

Review 1.  Exercise in cardiac rehabilitation.

Authors:  T Kavanagh
Journal:  Br J Sports Med       Date:  2000-02       Impact factor: 13.800

2.  The middle-aged marathon runner.

Authors:  A S Valentine
Journal:  Can Fam Physician       Date:  1982-05       Impact factor: 3.275

3.  On the choice of fluid for the hydration of middle-aged marathon runners.

Authors:  T Kavanagh; R J Shephard
Journal:  Br J Sports Med       Date:  1977-04       Impact factor: 13.800

4.  Exercise and the Olympic bounce.

Authors:  John Brooks
Journal:  Br J Gen Pract       Date:  2013-02       Impact factor: 5.386

Review 5.  Thermoregulation and marathon running: biological and environmental influences.

Authors:  S N Cheuvront; E M Haymes
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

6.  Predicting the exercise catastrophe in the post-coronary patient.

Authors:  R J Shephard; T Kavanagh
Journal:  Can Fam Physician       Date:  1978-06       Impact factor: 3.275

Review 7.  Historical Context of Cardiac Rehabilitation: Learning From the Past to Move to the Future.

Authors:  Julie Redfern; Robyn Gallagher; Adrienne O'Neil; Sherry L Grace; Adrian Bauman; Garry Jennings; David Brieger; Tom Briffa
Journal:  Front Cardiovasc Med       Date:  2022-04-27

8.  British pilot study of exercise therapy. II. Patients with cardiovascular disease.

Authors:  P G Nixon; M E Carruthers; D J Taylor; H J Bethell; W Grabau
Journal:  Br J Sports Med       Date:  1976-06       Impact factor: 13.800

9.  Prognosis in myocardial infarction--the benefits of exercise as seen in non-randomised trials.

Authors:  R J Shephard; T Kavanagh; J Kennedy; S Qureshi
Journal:  Br J Sports Med       Date:  1981-03       Impact factor: 13.800

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.